News

April 29, 2015 3:02 pm
Bristol-Myers Squibb (BMS) has opened an expanded access protocol for its monoclonal antibody elotuzumab in combination with Revlimid® and dexamethasone. Expanded access is a process regulated by the Food and Drug Administration (FDA) that allows...
April 1, 2015 3:14 pm
The IMF debuts a new way for patients and their loved ones to share their myeloma stories with “Myeloma Voices: An IMF Audio Archive.” Launched at the Boca Raton Patient & Family Seminar, the archive features oral historian Ryan White...
April 1, 2015 3:14 pm
Amgen received encouraging news with the FDA granting priority review to the company’s supplemental new drug application for its multiple myeloma drug, Kyprolis. Amgen is looking to convert Kyprolis’ accelerated approval to full approval and to...
April 1, 2015 3:14 pm
Order a Free Pillow Talk Care Package that includes a pillow-decorating project as well as materials that will help begin those often-difficult conversations.

Pages